- Home
- ELDN vs FMAO Comparison
ELDN vs FMAO Comparison
Compare ELDN & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- FMAO
- Stock Information
- Founded
- ELDN 2004
- FMAO 1897
- Country
- ELDN United States
- FMAO United States
- Employees
- ELDN N/A
- FMAO N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- FMAO Savings Institutions
- Sector
- ELDN Health Care
- FMAO Finance
- Exchange
- ELDN Nasdaq
- FMAO Nasdaq
- Market Cap
- ELDN 288.5M
- FMAO 344.8M
- IPO Year
- ELDN N/A
- FMAO N/A
- Fundamental
- Price
- ELDN $4.09
- FMAO $27.28
- Analyst Decision
- ELDN Strong Buy
- FMAO Hold
- Analyst Count
- ELDN 1
- FMAO 2
- Target Price
- ELDN $16.00
- FMAO $26.00
- AVG Volume (30 Days)
- ELDN 520.7K
- FMAO 22.4K
- Earning Date
- ELDN 11-12-2024
- FMAO 02-11-2025
- Dividend Yield
- ELDN N/A
- FMAO 3.23%
- EPS Growth
- ELDN N/A
- FMAO N/A
- EPS
- ELDN N/A
- FMAO 1.69
- Revenue
- ELDN N/A
- FMAO $98,003,000.00
- Revenue This Year
- ELDN N/A
- FMAO N/A
- Revenue Next Year
- ELDN N/A
- FMAO $8.11
- P/E Ratio
- ELDN N/A
- FMAO $16.17
- Revenue Growth
- ELDN N/A
- FMAO N/A
- 52 Week Low
- ELDN $1.52
- FMAO $18.99
- 52 Week High
- ELDN $5.54
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- ELDN 47.03
- FMAO 43.10
- Support Level
- ELDN $3.68
- FMAO $25.67
- Resistance Level
- ELDN $4.19
- FMAO $27.87
- Average True Range (ATR)
- ELDN 0.32
- FMAO 1.26
- MACD
- ELDN -0.04
- FMAO 0.01
- Stochastic Oscillator
- ELDN 31.54
- FMAO 49.71
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.